HSPA5 and cancer: In consistent with other studies showing silencing of GRP78 decreases cell growth and sensitizes cancer cells to chemotherapy [51, 52], our results proved that downregulation of GRP78 by administration of ISL also enhanced the treatment effect of Cisplatin (Figure 4).